Literature DB >> 33261279

Allograft versus autograft in forearm aseptic non-union treatment.

G Rollo1, F Luceri2, L Mangiavini2,3, L Meccariello1, M Bisaccia4, R M Lanzetti5, A Luceri6, M Agnoletto2, A A Llaquet-Leiva7.   

Abstract

Non-union in forearm fractures is an uncommon challenging clinical condition for orthopaedic surgeons. The complex anatomy and biomechanics of the upper limb make this surgery very demanding. The accurate restoration of the normal anatomy is mandatory to obtain bone healing. Infections and important bone loss further reduce the therapeutic success. The use of bone graft in atrophic non-union may significantly reduce the bone healing time with good clinical results. The aim of the study was to compare fresh-frozen bone (FFB) allograft and autograft in the treatment of forearm aseptic non-union. Inclusion criteria were patients aged between 18 to 75 years old with forearm aseptic shaft non-union treated with plating and bone grafting. The Authors retrospectively evaluated minimum 12-month follow-up with standard X-rays and clinical outcomes. All non-unions were classified according Association for the Study and Application of the Method of Ilizarov (ASAMI) classification for long bones. The sample size was divided in two groups: patients treated with FFB allograft (Allograft Group) and patients treated with iliac crest autograft (Autograft Group). The mean patient age was 33.58±16.72 (18-75) years old in Allograft Group and 33.28±17.24 (18-75) in Autograft Group. The mean follow-up was 62.6 months (±12.3, range 12-160) in Allograft Group and 64.4 (±12.4; 12-160) in Autograft Group. The mean bone union time after the surgery was 101.6 (±14.6; 82 -156) days in Allograft while 117.6 (±14.6; 90 -180) days for autograft. The Radiographic Union Score was 26.8 (±2.2; range 24.3-30) in Allograft while 26.9 (±2.8; range 24.1-30) in Autograft. A correlation between clinical and radiographic outcomes was found (Cohen κ: 0.86±0.11 in Allograft Group; Cohen κ: 0.85±0.10 in Autograft Group, p=0.051). The preoperative surgical planning is essential to apply this technique: the adequate cortical graft length is the key point to gain adequate implant stability. A meticulous surgical technique is mandatory to obtain good clinical and radiological outcomes. The study reported a good reliability of FFB allograft for large non-union bone defects. This technique may represent a feasible alternative to bone transport or amputation, as it allows the return to daily life activities. Further studies are needed to assess the long-term clinical results of this surgical procedure. Copyright 2020 Biolife Sas. www.biolifesas.org.

Entities:  

Keywords:  allograft; autograft; bone healing; bone loss; forearm; non-union; trauma

Year:  2020        PMID: 33261279

Source DB:  PubMed          Journal:  J Biol Regul Homeost Agents        ISSN: 0393-974X            Impact factor:   1.711


  3 in total

1.  Distal and/or Proximal Joint Stiffness Among Post-Fracture Patients Treated in University of Gondar Comprehensive Specialized Hospital, Gondar, Ethiopia.

Authors:  Moges Gashaw; Fantu Mamo Aragaw; Ashenafi Zemed; Mastewal Endalew; Nuhamin Tesfa Tsega; Melaku Hunie Asratie; Daniel Gashaneh Belay
Journal:  Orthop Res Rev       Date:  2022-05-12

2.  Novel Radiographic Indexes for Elbow Stability Assessment: Part B-Preliminary Clinical Study.

Authors:  Francesco Luceri; Davide Cucchi; Paolo Angelo Arrigoni; Pietro Simone Randelli; Enrico Rosagrata; Carlo Eugenio Zaolino; Alessandra Menon; Mattia Radici; Andrea Zagarella; Michele Catapano; Mauro Battista Gallazzi
Journal:  Indian J Orthop       Date:  2021-04-28       Impact factor: 1.251

3.  Novel Radiographic Indexes for Elbow Stability Assessment: Part A-Cadaveric Validation.

Authors:  Francesco Luceri; Davide Cucchi; Paolo Angelo Arrigoni; Pietro Simone Randelli; Enrico Rosagrata; Carlo Eugenio Zaolino; Marco Viganò; Laura de Girolamo; Andrea Zagarella; Michele Catapano; Mauro Battista Gallazzi
Journal:  Indian J Orthop       Date:  2021-05-09       Impact factor: 1.251

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.